Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 501–524 of 524 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04045717	Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0	active not recruiting	Phase 2	124	Universitaire Ziekenhuizen KU LeuvenOTHER	2	Dec 1, 2023	clinicaltrials
NCT03459820	Prostate Cancer Patient Management With 18F-DCFPyL PET/CT	enrolling by invitation	Phase 2 / Phase 3	1,500	Sir Mortimer B. Davis - Jewish General HospitalOTHER	1	Nov 27, 2023	clinicaltrials